Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages.
about
Complement and macrophage crosstalk during process of angiogenesis in tumor progressionElectronegative LDL: a circulating modified LDL with a role in inflammationOn the Functional Overlap between Complement and Anti-Microbial PeptidesSmoke exposure causes endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation.SAK-HV Triggered a Short-period Lipid-lowering Biotherapy Based on the Energy Model of Liver Proliferation via a Novel Pathway.Protective role for properdin in progression of experimental murine atherosclerosis.Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese womenTargeted complement inhibition and microvasculature in transplants: a therapeutic perspective.FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells.Insulin-Mediated Downregulation of Apolipoprotein A-I Gene in Human Hepatoma Cell Line HepG2: The Role of Interaction Between FOXO1 and LXRβ Transcription Factors.Production of complement components by cells of the immune system.More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.Complement C3 as a marker of cardiometabolic risk in psoriasis.PPARγ Represses Apolipoprotein A-I Gene but Impedes TNFα-Mediated ApoA-I Downregulation in HepG2 Cells.Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.
P2860
Q26801339-06121623-E8CB-44A0-BB60-66183A2F556DQ27015769-69F7F6DD-E8A5-4E2C-A027-339AC19F0A21Q28082379-A2220304-0745-4DA2-A37A-634045AAEE39Q33652041-D513BBFF-92DF-4A6F-B698-4319AB68317FQ33703148-715A8766-8C54-4B4B-82EF-C9DD05D0D2E9Q35131403-61D4A303-B280-4F44-8C4C-46DC86EF8D64Q35151778-72DEA128-A47D-475B-ACEC-9DC89334A78AQ38592520-B94482AD-F2D9-43A3-9F22-7A3025DD9FEBQ38728466-772C9AF2-BB02-47F6-B5D6-F0FAD14EA489Q38758630-B825CDD8-3248-4E4D-85AA-2D21F3F67C27Q38935414-8DFCEC8A-9D51-45C6-AE38-C942A2FBAD71Q38991040-22CB5FAA-439A-44C8-A822-2E2C96F5B1FEQ39188717-3799C3D3-A788-4CA3-99C8-311E6EA34F4FQ40058224-CAE5F190-7230-4EB7-8B1C-50219B5A51B7Q42798325-35CD4C15-77F3-4D1B-BA76-EC3027FFD4DD
P2860
Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Modified low density lipoprote ...... tivation in human macrophages.
@en
type
label
Modified low density lipoprote ...... tivation in human macrophages.
@en
prefLabel
Modified low density lipoprote ...... tivation in human macrophages.
@en
P2093
P2860
P50
P356
P1476
Modified low density lipoprote ...... ctivation in human macrophages
@en
P2093
Alexander M Ischenko
Alexander V Zhakhov
Andrey S Trulioff
Boris V Missyul
Ella B Dizhe
Igor V Kudriavtsev
P2860
P304
P356
10.1074/JBC.M111.289322
P407
P577
2011-12-22T00:00:00Z